Search Results - "Kakiki, M"

Refine Results
  1. 1

    A multi-throughput multi-organ-on-a-chip system on a plate formatted pneumatic pressure-driven medium circulation platform by Satoh, T, Sugiura, S, Shin, K, Onuki-Nagasaki, R, Ishida, S, Kikuchi, K, Kakiki, M, Kanamori, T

    Published in Lab on a chip (01-01-2018)
    “…This paper reports a multi-throughput multi-organ-on-a-chip system formed on a pneumatic pressure-driven medium circulation platform with a microplate-sized…”
    Get more information
    Journal Article
  2. 2

    Cardiovascular Assessment of ER-118585, a Selective Phosphodiesterase 5 Inhibitor by Mizuno, Hiroshi, Adachi, Hideyuki, Kimura, Junko, Sawa, Yoshio, Kakiki, Motoharu, Lansdell, Kate, Saito, Mamoru, Kerns, William David

    Published in Biological & Pharmaceutical Bulletin (01-12-2003)
    “…The aim of this study was to assess the cardiovascular effects of a selective phosphodiesterase 5 inhibitor ER-118585,…”
    Get full text
    Journal Article
  3. 3

    Pharmacokinetics, metabolism and pharmacodynamics of a benzimidazole angiotensin II type 1 receptor antagonist in the beagle dog and cynomologus monkey by KAKIKI, M, ISHIHARA, H

    Published in Xenobiotica (1998)
    “…1. The pharmacokinetics and disposition of E4177, an angiotensin II (Ang II) type 1 receptor antagonist, were studied in the beagle dog and cynomologus monkey…”
    Get full text
    Journal Article
  4. 4

    Localization and disposition of a non-peptide angiotensin II type 1 receptor antagonist, and its glucuronide metabolite, in rat by KAKIKI, M., TADANO, K.

    Published in Xenobiotica (01-07-1997)
    “…1. The disposition of radioactivity of a non-peptide angiotensin II type 1 receptor antagonist (E4177) has been studied in groups of male rats after a single…”
    Get full text
    Journal Article
  5. 5

    Species differences and mechanism of the epimerization of a new MAO-A inhibitor by NAITOH, T., KAWAGUCHI, S., KAKIKI, M., OHE, H., KAJIWARA, A., HORIE, T.

    Published in Xenobiotica (01-03-1998)
    “…1. (5R)-3-[2-((1S)-3-cyano-1-hydroxypropyl)benzothiazol-6-yl]-5-methoxymethyl2-oxazolidinone (E2011) has two chiral centers in its structure. In vivo optical…”
    Get full text
    Journal Article
  6. 6

    Identification of the metabolites of a new oxazolidinone MAO-A inhibitor in rat by NAITOH, T., KAKIKI, M., KOZAKI, T., MISHIMA, M., YUZURIHA, T., HORIE, T.

    Published in Xenobiotica (01-10-1997)
    “…1. Six metabolites present in rat urine after the oral administration of E2011…”
    Get full text
    Journal Article
  7. 7

    Absorption, distribution, metabolism and excretion of a new, 14C-labelled oxazolidinone MAO-A inhibitor in rat and dog by NAITOH, T., MISHIMA, M., KAWAGUCHI, S., MATSUI, K., ANDOH, T., KAGEI, K., KAKIKI, M., YUZURIHA, T., HORIE, T.

    Published in Xenobiotica (01-10-1997)
    “…1. After oral administration of 14C-labelled (5R)-3-\[2-((1S)-3-cyano-1-hydroxypropyl)benzothiazol-6-yl]-5-methoxymethyl-2-oxazolidinone (E2011) at a dose of 1…”
    Get full text
    Journal Article
  8. 8

    Effects of a phosphodiesterase 3 inhibitor, olprinone, on rhythmical change in tension of human gastroepiploic artery by Adachi, Hideyuki, Kakiki, Motoharu, Kishi, Yoshihiko

    Published in European journal of pharmacology (28-12-2005)
    “…The gastroepiploic artery, used widely as a conduit in coronary artery bypass grafting, has high vasospasticity. The aims of this study were to examine the…”
    Get full text
    Journal Article
  9. 9

    Stereoselective determination of a new antidepressant, E2011, and its diastereoisomer as a metabolite by high-performance liquid chromatography by Naitoh, T, Kakiki, M, Kawaguchi, S, Kagei, Y, Horie, T

    “…A stereoselective HPLC method has been developed for the determination of E2011 (compound I) and one of its metabolites and diastereoisomers, ER-20593…”
    Get full text
    Journal Article
  10. 10

    Immunohistochemical study of cytochrome P450 2C and 3A in human non-neoplastic and neoplastic tissues by YOKOSE, T, DOY, M, TANIGUCHI, T, SHIMADA, T, KAKIKI, M, HORIE, T, MATSUZAKI, Y, MUKAI, K

    “…Organ and cellular distribution and expression constancy of microsomal cytochrome P450 (CYP) 2C and 3A in humans were studied with new polyclonal antibodies to…”
    Get full text
    Journal Article
  11. 11

    Pharmacokinetics, metabolism and pharmacodynamic s of a benzimidazole angiotensin II type 1 receptor antagonist in the beagle dog and cynomologus monkey by KAKIKI, M., ISHIHARA, H.

    Published in Xenobiotica (1998)
    “…1. The pharmacokinetic s and disposition of E4177, an angiotensin II (Ang II) type 1 receptor antagonist, were studied in the beagle dog and cynomologus monkey…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Expression of aldosterone synthase cytochrome P450 (P450aldo) mRNA in rat adrenal glomerulosa cells by angiotensin II type 1 receptor by Kakiki, M, Morohashi, K, Nomura, M, Omura, T, Horie, T

    Published in Endocrine research (01-11-1997)
    “…Changes in the mRNA levels for aldosterone synthase cytochrome P450 (P450aldo or CYP11B2) in rat adrenal glands were studied in response to angiotensin II type…”
    Get full text
    Journal Article
  14. 14

    Expression of aldosterone synthase cytochrome P450 (P450aldo) mRNA in rat adrenal glomerulosa cells by angiotensin ii type1 receptor by Kakiki, M., Morohashi, K., Nomura, M., Omura, T., Horie, T.

    Published in Endocrine research (1997)
    “…Changes in the mRNA levels for aldosterone synthase cytochrome P450 (P450aldo or CYP11B2) in rat adrenal glands were studied in response to angiotensin II type…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Expression of Cytochrome P450 3A4 in Foveolar Epithelium with Intestinal Metaplasia of the Human Stomach by Yokose, Tomoyuki, Doy, Mikio, Kakiki, Motoharu, Horie, Tohru, Matsuzaki, Yasushi, Mukai, Kiyoshi

    Published in Cancer science (01-10-1998)
    “…The expression of cytochrome P450 3A4 (CYP3A4) in the foveolar epithelium of the human stomach with intestinal metaplasia was studied using…”
    Get full text
    Journal Article
  17. 17

    Localization of a Novel Non-peptide Angiotensin II Type 1 Receptor Antagonist, E4177, in Rat Adrenal Glomerulosa by KAKIKI, Motoharu, HORIE, Toru

    “…We investigated the distribution of a novel angiotensin II type 1 (AT1) receptor antagonist, E4177 (4'-[2-cyclopropyl-7-methyl-3H-imidazo[5,…”
    Get full text
    Journal Article
  18. 18

    Absorption, distribution, metabolism and excretion of a new, super(14)C-labelled oxazolidinone MAO-A inhibitor in rat and dog by Naitoh, T, Mishima, M, Kawaguchi, S, Matsui, K, Andoh, T, Kagei, K, Kakiki, M, Yuzuriha, T, Horie, T

    Published in Xenobiotica (01-10-1997)
    “…After oral administration of super(14)C-labelled (5R)-3-[2-((1S)-3-cyano-1-hydroxypropyl)benzothiazol-6-yl]-5-metho x ymethyl-2-oxazolidinone (E2011) at a dose…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Some properties of tissue-type plasminogen activator reconstituted onto phospholipid and/or glycolipid vesicles by Soeda, S, Kakiki, M, Shimeno, H, Nagamatsu, A

    “…Porcine heart tissue-type plasminogen activator (t-PA) was reconstituted onto large multilamellar liposomes with various lipid compositions and the kinetics of…”
    Get more information
    Journal Article